| Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application C Sinning, L Lillpopp, S Appelbaum, F Ojeda, T Zeller, R Schnabel, ... Clinical Research in Cardiology 102, 495-503, 2013 | 199 | 2013 |
| Rationale and design of the Hamburg city health study A Jagodzinski, C Johansen, U Koch-Gromus, G Aarabi, G Adam, ... European journal of epidemiology 35, 169-181, 2020 | 112 | 2020 |
| β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial C Espinola-Klein, G Weisser, A Jagodzinski, S Savvidis, A Warnholtz, ... Hypertension 58 (2), 148-154, 2011 | 95 | 2011 |
| ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality MF Hughes, S Appelbaum, AS Havulinna, A Jagodzinski, T Zeller, F Kee, ... Heart 100 (21), 1715-1721, 2014 | 68 | 2014 |
| Predictive value of galectin-3 for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort A Jagodzinski, AS Havulinna, S Appelbaum, T Zeller, P Jousilahti, ... International Journal of Cardiology 192, 33-39, 2015 | 67 | 2015 |
| Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease JT Neumann, S Tzikas, A Funke-Kaiser, S Wilde, S Appelbaum, T Keller, ... Atherosclerosis 228 (2), 451-459, 2013 | 61 | 2013 |
| Oral supplementation with L‐homoarginine in young volunteers D Atzler, M Schönhoff, K Cordts, I Ortland, J Hoppe, FC Hummel, C Gerloff, ... British journal of clinical pharmacology 82 (6), 1477-1485, 2016 | 54 | 2016 |
| Die Basiserhebung der NAKO Gesundheitsstudie: Teilnahme an den Untersuchungsmodulen, Qualitätssicherung und Nutzung von Sekundärdaten S Schipf, G Schöne, B Schmidt, K Günther, G Stübs, KH Greiser, ... Robert Koch-Institut, 2020 | 52 | 2020 |
| Transcriptome-wide analysis identifies novel associations with blood pressure T Zeller, C Schurmann, K Schramm, C Müller, S Kwon, PS Wild, A Teumer, ... Hypertension 70 (4), 743-750, 2017 | 42 | 2017 |
| Network localisation of white matter damage in cerebral small vessel disease M Petersen, BM Frey, E Schlemm, C Mayer, U Hanning, K Engelke, ... Scientific reports 10 (1), 9210, 2020 | 32 | 2020 |
| Linking cortical atrophy to white matter hyperintensities of presumed vascular origin C Mayer, BM Frey, E Schlemm, M Petersen, K Engelke, U Hanning, ... Journal of Cerebral Blood Flow & Metabolism 41 (7), 1682-1691, 2021 | 28 | 2021 |
| Applying the ESC 2016, H2FPEF, and HFA‐PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the general population J Nikorowitsch, R Bei der Kellen, P Kirchhof, C Magnussen, A Jagodzinski, ... ESC Heart Failure 8 (5), 3603-3612, 2021 | 27 | 2021 |
| White matter integrity and structural brain network topology in cerebral small vessel disease: the Hamburg city health study BM Frey, M Petersen, E Schlemm, C Mayer, U Hanning, K Engelke, ... Human brain mapping 42 (5), 1406-1415, 2021 | 24 | 2021 |
| The baseline assessment of the German National Cohort (NAKO Gesundheitsstudie): participation in the examination modules, quality assurance, and the use of secondary data S Schipf, G Schöne, B Schmidt, K Günther, G Stübs, KH Greiser, ... Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 63, 254-266, 2020 | 21 | 2020 |
| Cardiovascular magnetic resonance imaging in the prospective, population-based, Hamburg City Health cohort study: objectives and design S Bohnen, M Avanesov, A Jagodzinski, RB Schnabel, T Zeller, M Karakas, ... Journal of Cardiovascular Magnetic Resonance 20, 1-11, 2018 | 17 | 2018 |
| Fixel based analysis of white matter alterations in early stage cerebral small vessel disease M Petersen, BM Frey, C Mayer, S Kühn, J Gallinat, U Hanning, J Fiehler, ... Scientific reports 12 (1), 1581, 2022 | 15 | 2022 |
| Novel approaches for BAV aortopathy prediction—is there a need for cohort studies and biomarkers? E Girdauskas, J Petersen, N Neumann, S Naito, T Gross, A Jagodzinski, ... Biomolecules 8 (3), 58, 2018 | 15 | 2018 |
| Cardiovascular Biomarkers in Hypertensive Patients with Medical Treatment—Results from the Randomized TEAMSTA Protect I Trial A Jagodzinski, JT Neumann, F Ojeda, NA Sörensen, P Wild, T Münzel, ... Clinical chemistry 63 (12), 1877-1885, 2017 | 15 | 2017 |
| The value of circulating biomarkers in bicuspid aortic valve-associated aortopathy S Naito, M Hillebrand, AMJ Bernhardt, A Jagodzinski, L Conradi, C Detter, ... The Thoracic and Cardiovascular Surgeon 66 (04), 278-286, 2018 | 14 | 2018 |
| Added clinical value of applying myocardial deformation imaging to assess right ventricular function V Sokalskis, D Peluso, A Jagodzinski, C Sinning Echocardiography 34 (6), 919-927, 2017 | 12 | 2017 |
